Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Consolidated Net Profit

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

DIVIS LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹2,191 Cr₹1,600 Cr₹1,824 Cr₹2,960 Cr₹1,984 Cr

What is the latest Consolidated Net Profit of DIVIS LABORATORIES ?

The latest Consolidated Net Profit ratio of DIVIS LABORATORIES is ₹2,191 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹2,191 Cr
Mar2024₹1,600 Cr
Mar2023₹1,824 Cr
Mar2022₹2,960 Cr
Mar2021₹1,984 Cr

How is Consolidated Net Profit of DIVIS LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹2,191 Cr
36.94
Mar2024 ₹1,600 Cr
-12.28
Mar2023 ₹1,824 Cr
-38.39
Mar2022 ₹2,960 Cr
49.19
Mar2021 ₹1,984 Cr -

Compare Consolidated Net Profit of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹167,051.3 Cr 2.3% 3.6% 7.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics
MANKIND PHARMA ₹83,688.0 Cr -2.6% -5.6% -15% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

2.3%

3.6%

7.8%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses